Tatva Chintan Pharma Chem Limited (NSE:TATVA)

India · Delayed Price · Currency is INR

1,294.30

-36.10 (-2.71%)

Apr 29, 2026, 3:29 PM IST

79.81% (1Y)

Market Cap	31.12B
Revenue (ttm)	4.80B
Net Income (ttm)	327.63M
Shares Out	23.39M
EPS (ttm)	14.02
PE Ratio	94.91
Forward PE	50.71
Dividend	1.00 (0.08%)
Ex-Dividend Date	Sep 12, 2025

Volume	30,486
Average Volume	45,122
Open	1,325.00
Previous Close	1,330.40
Day's Range	1,292.00 - 1,340.00
52-Week Range	672.00 - 1,610.00
Beta	0.34
RSI	57.88
Earnings Date	May 4, 2026

About Tatva Chintan Pharma Chem

Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and brominated flame retardants. The company serves automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal car... [Read more]

Industry Specialty Chemicals

Sector Materials

Founded 1996

Employees 679

Stock Exchange National Stock Exchange of India

Ticker Symbol TATVA

Full Company Profile

Financial Performance

In fiscal year 2025, Tatva Chintan Pharma Chem's revenue was 3.83 billion, a decrease of -2.74% compared to the previous year's 3.94 billion. Earnings were 57.13 million, a decrease of -81.18%.

Financial Statements

News

There is no news available yet.